8054 J. Am. Chem. Soc., Vol. 122, No. 33, 2000
HaVrilla et al.
solution was colorless. BHT (∼3 mg) was added and the ether removed
in vacuo. The resulting bright yellow oil was purified by flash
chromatography on silica gel (20% Et2O in hexanes) yielding 0.9736
g of a pale yellow oil (80.5%): TLC: Rf 0.21 (25% Et2O in hexanes);
1H NMR (400 MHz, CDCl3): δ 8.42 (s, 1H), 6.51 (dd, J ) 15.2, 11.1
Hz, 1H), 5.94 (t, J ) 10.9, 10.9 Hz, 1H), 5.55 (dd, J ) 15.2, 8.0 Hz,
1H), 5.32 (m, 5H), 4.30 (m, 1H), 3.59 (s, 3H), 2.89 (m, 2H), 2.73 (m,
2H), 2.25 (m, 2H), 2.03 (m, 2H), 1.61 (m, 3H), 1.43-1.16 (8H), 0.81
(t, 3H); 13C NMR (100 MHz, CDCl3): δ 174.26, 133.52, 132.28,
130.62, 128.78, 128.47, 127.69, 127.21, 86.21, 60.41, 51.41, 33.20,
32.40, 31.56, 26.33, 25.95, 25.43, 24.77, 24.51, 22.31, 13.81; FTIR
(neat, NaCl plates): 3417.7 (s), 1717.26 (s) cm-1; CIS-MS (DLI,
AgBF4): m/z 457.0/459.1[M + Ag]+.
25.43, 25.08, 24.93, 24.86, 24.67, 24.26, 23.80, 23.02, 22.83, 22.80,
22.54, 22.50, 21.00, 19.30, 18.69. 14.03, 11.83; FTIR (neat, NaCl
plates): 1732.56 (s) cm-1; CIS-MS (DLI, AgBF4): m/z 883.6/885.6
[M + Ag]+.
Cholesteryl 15(S)-hydroperoxy-5(Z),8(Z),11(Z),13(E)-eicosatet-
raenoate, 17. The protected cholesteryl arachidonate hydroperoxide
(0.7519 g, 0.967 mmol) was dissolved in THF (9 mL). BHT (∼3 mg)
was added to the solution to prevent hydroperoxide rearrangement.
Glacial acetic acid (5 mL) and deionized water (3 mL) were added
with stirring resulting in a cloudy white solution, which was stirred
overnight under argon. The reaction was worked up by drying with
anhydrous NaSO4, followed by removal of the acetic acid by azeotrope
with cyclohexane. The crude material was purified by flash column
chromatography (5% EtOAc in hexanes), resulting in the recovery of
0.0321 g of the starting protected hydroperoxide and 0.5183 g of the
desired hydroperoxide (76.0%): TLC: Rf 0.38 (15% EtOAc in
hexanes); 1H NMR (400 MHz, CDCl3): δ 8.33 (s, 1H), 6.49 (dd, J )
15.2, 11.1 Hz, 1H), 5.91 (t, J ) 10.9, 10.9 Hz, 1H), 5.51 (dd, J )
15.2, 8.0 Hz, 1H), 5.30 (m, 6H), 4.52 (m, 1H), 4.27 (q, 14.0, 6.7 Hz,
1H), 2.86 (m, 2H), 2.71 (m, 2H), 2.19 (m, 4H), 2.03-0.75 (53H), 0.57
(s, 3H); 13C (100 MHz, CDCl3): δ 173.26, 139.50, 132.22, 130.90,
129.10, 129.03, 128.70, 128.55, 128.22, 127.73, 127.27, 122.58, 86.41,
73.89, 56.60, 56.06, 49.93, 42.23, 39.65, 39.45, 38.05, 36.90, 36.50,
36.12, 35.73, 33.97, 32.54, 31.82, 31.77, 31.71, 28.16, 27.94, 27.72,
26.50, 26.12, 25.58, 24.92, 24.78, 24.21, 23.77, 22.76, 22.50, 20.96,
19.24, 18.651, 13.97, 11.79; CIS-MS (DLI, AgBF4): m/z 811.6/813.6
[M + Ag]+.
Conversion of 15-OOH Cholesteryl Arachidonate (Ch-15-
HPETE) to More Polar Compounds. A solution of Ch-15-HPETE
(17, 0.2858 g, 0.405 mmol) was dissolved in dry benzene (2.7 mL) for
a final lipid concentration of 0.15 M. DTBN (7.2 mg, 0.041 mmol, 10
mol %) was added, and the lipid mixture was stirred at 37 °C in an oil
bath under an atmosphere of oxygen for 16-18 h. BHT (∼2 mg) was
added and the reaction was stored at -78 °C until HPLC and MS
analysis. The reaction was repeated for a total of 0.5781 g of Ch-15-
HPETE converted to more polar products. The analytical traces of each
individual conversion were identical to one another, so the mixtures
were pooled. The polar compounds were isolated by semipreparative
HPLC (1.0% 2-propanol in hexanes, 10 mL/min). Typically, 15-20
mg of the oxidized material was separated per injection to prevent
column overloading. Several major UV active (λ ) 234 nm) fractions
were collected (B, C, E, F/G, I). Minor fractions (A, D, H, J) were
also collected, but were typically mixtures of 2-4 compounds. The
major fractions were analyzed by 1H NMR, two-dimensional correlation
spectroscopy (2D COSY), and CIS-MS.
Direct Liquid Injection Analysis (DLI) and HPLC-MS Analysis
of More Polar Cyclic Peroxides. Individual isolated fractions (B, C,
E, F/G, I) were analyzed by direct liquid infusion of the sample as
described for the cholesteryl linoleate hydroperoxides. For on-line LC-
CIS-MS analysis of cyclic peroxide mixtures, sample introduction was
carried out using a single Beckman Ultrasphere narrowbore 5-µm silica
column (2.0 mm × 25 cm) operated in the isocratic mode with 1.0%
2-propanol in hexanes at a flow rate of 150 µL/min. A stock solution
of the Ch-15-HPETE conversion mixture (1 mg/mL in mobile phase)
was prepared in mobile phase and typically 20-40 µL (20-40 µg lipid)
of the solution was injected per analysis. Offset voltages for SRM
experiments, usually 20 eV were set as determined by optimization in
the DLI experiments
Conversion of 5-OOH Cholesteryl Arachidonate (Ch-5-HPETE)
to More Polar Compounds. Ch-5-HPETE (12) was isolated from a
cholesteryl arachidonate autoxidation with 1,4-cyclohexadiene, as
already described. The isolated hydroperoxide (6.8 mg, 9.64 × 10-3
mmol) was dissolved in benzene (195 µL). DTBN was added as a
benzene solution (65 µL of 2.7 mg/mL, 0.176 mg, 1 × 10-3 mmol, 10
mol % DTBN) for a final lipid concentration of 0.0375 M. The reaction
vial was flushed with oxygen, sealed, and stirred at 37 °C for 17 h.
BHT (∼2 mg) was added and the reaction was stored at -78 °C until
analysis. LC/CIS-MS was performed as described for the above cyclic
product mixtures.
Methyl 15(S)-[(1-methoxy-1-methylethyl)dioxy]-5(Z),8(Z),11(Z),-
13(E)-eicosatetraenoate. Methyl arachidonate hydroperoxide (0.8538
g, 2.44 mmol) was dissolved in dry CH2Cl2 (14 mL). To this solution,
2-methoxypropene (360 µL, 0.263 g, 3.65 mmol) and pyridinium-p-
toluenesulfonate (∼2 mg) were added. The reaction was stirred
overnight at room temperature under argon. The reaction was added
to a separatory funnel with CH2Cl2 (50 mL). The organic layer was
washed with NaHCO3 (1 × 20 mL) and saturated NaCl (1 × 20 mL),
dried with MgSO4, and concentrated to dryness to yield 1.22 g of a
1
yellow oil (100%): TLC: Rf 0.35 (25% Et2O in hexanes); H NMR
(400mHz, CDCl3): δ 6.47 (dd, J ) 15.2, 11.1 Hz, 1H), 5.98 (t, J )
11.2, 11.2 Hz, 1H), 5.61 (dd, J ) 15.2, 7.9 Hz, 1H), 5.35 (m, 5H),
4.37 (m, 1H), 3.63 (s, 3H), 3.25 (s, 3H), 2.92 (m, 2H), 2.77 (m, 2H),
2.28 (t, 2H), 2.07 (q, 2H), 1.66 (m, 3H), 1.43-1.22 (13H), 0.84 (t,
3H); 13C NMR (100 MHz, CDCl3): δ 173.95, 133.60, 130.08, 128.98,
128.65, 128.53, 128.17, 127.56, 127.40, 104.51, 84.56, 51.41, 49.20,
33.35, 33.03, 31.73, 26.49, 26.06, 25.56, 25.05, 24.71, 22.98, 22.79,
22.47, 13.98; FTIR (neat, NaCl plate) 1738.12 cm-1; CIS-MS (DLI,
AgBF4): m/z 529.1/531.1 [M + Ag]+.
15(S)-[(1-Methoxy-1-methylethyl)dioxy]-5(Z),8(Z),11(Z),13(E)-
eicosatetraenoic Acid. The protected methyl arachidonate hydroper-
oxide (1.0358 g, 2.4510 mmol) was dissolved in tetrahydrofuran (THF,
10 mL) and LiOH (4.0 M, 10 mL). The biphasic solution was vigorously
stirred at room temperature overnight. The reaction was poured into a
separatory funnel containing 1 M HCl (60 mL) and EtOAc (50 mL).
The acidified layer was extracted with EtOAc (3 × 50 mL). The
combined organic layers were washed with brine (1 × 25 mL), dried
with anhydrous MgSO4, and concentrated to 1.0228 g of a bright yellow
oil (100% yield): TLC: Rf 0.09 (25% Et2O in hexanes), Rf 0.27 (50%
Et2O in hexanes); 1H NMR (400 MHz, CDCl3): δ 9.91 (bs, 1H), 6.48
(dd, J ) 15.2, 11.1 Hz, 1H), 5.98 (t, J ) 11.2, 11.2 Hz, 1H), 5.61 (dd,
J ) 15.2, 7.9 Hz, 1H), 5.36 (m, 5H), 4.38 (q, 1H), 3.26 (s, 3H), 2.93
(t, 2H), 2.78 (t, 2H), 2.33 (t, 2H), 2.10 (q, 2H), 1.67 (m, 3H), 1.44-
1.20 (13H), 0.85 (t, 3H); 13C NMR (100 MHz, CDCl3): δ 179.49,
133.51, 130.08, 128.81, 128.46, 128.16, 127.57, 127.44, 104.57, 84.54,
49.18, 33.30, 33.02, 31.72, 26.39, 26.06, 25.57, 25.02, 24.43, 22.94,
22.78, 22.46, 13.98; FTIR (neat, NaCl plates): 2923.21 (s), 1693.61
(s); CIS-MS (DLI, AgBF4): m/z 515.1/517.1 [M + Ag+].
Cholesteryl 15(S)-[(1-methoxy-1-methylethyl)dioxy]-5(Z),8(Z),-
11(Z),13(E)-eicosatetraenoate. The protected arachidonic acid hydro-
peroxide (0.6023 g, 1.47 mmol) was dissolved in dry CH2Cl2 (20 mL).
dimethylaminopyridine (0.3978 g, 3.26 mmol) and cholesterol (0.6932
g, 1.792 mmol) were added and stirred for 5 min. dicyclohexylcarbo-
diimide (0.6744 g, 3.26 mmol) was added in one portion, and the
reaction was stirred under argon for 24 h. TLC indicated the formation
of a less polar fraction, which stained pink with the hydroperoxide
stain after heating. After three flash columns (5% EtOAc in hexanes),
the protected cholesteryl ester hydroperoxide was obtained as 0.7519
g of a thick, colorless oil (65.7%): TLC: Rf 0.33 (10% EtOAc in
hexanes), Rf 0.51 (15% EtOAc in hexanes); 1H NMR (400 MHz,
CDCl3): δ 6.48 (dd, J ) 15.4, 11.1 Hz, 1H), 5.99 (t, J ) 11.2, 11.2
Hz, 1H), 5.62 (dd, J ) 15.5, 8.0 Hz, 1H), 5.36 (m, 6H), 4.59 (m, 1H),
4.39 (q, 14.0, 6.7 Hz, 1H), 3.27 (s, 3H), 2.94 (m, 2H), 2.79 (m, 2H),
2.27 (m, 4H), 2.11-0.83 (59H), 0.65 (s, 3H); 13C (100 MHz, CDCl3):
δ 172.95, 139.62, 133.62, 130.11, 129.14, 128.61,128.59, 128.21,
127.59, 127.44, 122.60, 104.54, 84.59, 73.77, 56.66, 56.10, 49.99, 49.24,
42.28, 39.70, 39.49, 38.13, 36.97, 36.57, 36.16, 35.77, 34.90, 34. 02,
33.06, 31.88, 31.83, 31.77, 28.21, 27.99, 27.79, 26.54, 26.10, 25.59,
Autoxidation of Cholesteryl Arachidonate without 1,4-Cyclo-
hexadiene. Cholesteryl arachidonate (0.400 g, 0.594 mmol) was